Shoulder Innovations Adds Medtech Veteran Drew Hykes to Board
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Shoulder Innovations, Inc. ( (SI) ) is now available.
On March 2, 2026, Shoulder Innovations announced that medtech veteran Drew Hykes joined its Board of Directors and Compensation Committee, effective February 26, 2026, while Independent Director Geoff Pardo resigned. The move signals a governance refresh as the company continues scaling adoption of its novel shoulder arthroplasty portfolio in a competitive orthopedic devices market.
Hykes brings more than 25 years of medical device operating experience, including senior leadership roles at Okami Medical, Inari Medical, Sequent Medical, and Medtronic, with a track record spanning commercialization, clinical and regulatory affairs, and investor relations. His appointment is expected to bolster Shoulder Innovations’ strategic execution and commercial capabilities as it seeks to expand access to its differentiated platform and strengthen its position in the shoulder surgical care segment.
The most recent analyst rating on (SI) stock is a Sell with a $12.50 price target. To see the full list of analyst forecasts on Shoulder Innovations, Inc. stock, see the SI Stock Forecast page.
Spark’s Take on SI Stock
According to Spark, TipRanks’ AI Analyst, SI is a Neutral.
The overall stock score is primarily influenced by financial performance challenges, including profitability and cash flow issues. However, positive technical indicators and a strategic partnership provide some optimism. The valuation remains a concern due to negative earnings, but the corporate event could improve future prospects.
To see Spark’s full report on SI stock, click here.
More about Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused exclusively on the shoulder surgical care market, offering advanced implant systems for shoulder arthroplasty. Its ecosystem integrates preoperative planning, implant design, enabling technologies, efficient instrument systems, specialized support, and surgeon-to-surgeon collaboration to improve outcomes and procedural efficiency across sites of care.
The company targets longstanding clinical and operational challenges in shoulder surgery by emphasizing predictable outcomes, procedural simplicity, and efficiency for all stakeholders in the care chain. Its market focus is on transforming shoulder arthroplasty through differentiated technology platforms that aim to drive adoption among surgeons and healthcare providers.
Average Trading Volume: 52,486
Technical Sentiment Signal: Strong Buy
Current Market Cap: $279.4M
See more data about SI stock on TipRanks’ Stock Analysis page.
